1. Home
  2. INSE vs MAIA Comparison

INSE vs MAIA Comparison

Compare INSE & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inspired Entertainment Inc.

INSE

Inspired Entertainment Inc.

N/A

Current Price

$4.50

Market Cap

83.6M

Sector

Technology

ML Signal

N/A

Logo MAIA Biotechnology Inc.

MAIA

MAIA Biotechnology Inc.

N/A

Current Price

$1.03

Market Cap

69.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INSE
MAIA
Founded
2002
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.6M
69.2M
IPO Year
2014
2022

Fundamental Metrics

Financial Performance
Metric
INSE
MAIA
Price
$4.50
$1.03
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$6.85
★ $12.00
AVG Volume (30 Days)
★ 516.7K
268.3K
Earning Date
11-05-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 33.33
EPS
★ N/A
N/A
Revenue
★ $199,800,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.15
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 30.25
N/A
52 Week Low
$3.10
$0.87
52 Week High
$9.95
$3.19

Technical Indicators

Market Signals
Indicator
INSE
MAIA
Relative Strength Index (RSI) 64.60 39.10
Support Level $3.20 N/A
Resistance Level $8.42 $1.48
Average True Range (ATR) 0.31 0.06
MACD 0.17 -0.00
Stochastic Oscillator 88.44 5.00

Price Performance

Historical Comparison
INSE
MAIA

About INSE Inspired Entertainment Inc.

Inspired Entertainment Inc is a gaming technology company, supplying content, platform and other products and services to licensed online and land-based lottery, betting and gaming operators of various countries through a range of distribution channels, on a business-to-business basis. The company provides digital gaming solutions (i) on its own proprietary and secure network, which accommodates a wide range of devices, including land-based gaming machine terminals, mobile devices and online computer applications, and (ii) through third party networks. It operates in four business segments: Gaming, Virtual Sports, Interactive and Leisure. The majority of revenue is derived from the Leisure Segment, which includes the supply of the gaming and amusement machines.

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of targeted immunotherapies for cancer, with an initial focus on non-small cell lung cancer (NSCLC), which represents the majority of lung cancer cases. Its asset, ateganosine (THIO, also known as 6-thio-dG or 6-thio-deoxyguanosine), is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The treatment approach involves administering THIO followed by the immune checkpoint inhibitor Libtayo (cemiplimab), which is manufactured and commercialized by Regeneron.

Share on Social Networks: